A recommendation of PHTALOX® for preventing infection and progression of COVID-19: a 1-year summarized update of scientific approaches

IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

GMS Hygiene and Infection Control Pub Date : 2022-01-31 DOI:10.3205/dgkh000406

Bernardo da Fonseca Orcina, Verônica-Caroline-Brito Reia, Andréa N.C. Simão, A. Lonni, T. Fernandes, M. L. Poleti, F. Vilhena, P. S. da Silva Santos

引用次数: 2

Abstract

Dear editor, The role of the oral cavity in the genesis, progression, and dissemination of COVID-19 has been revealed by breakthroughs in SARS-CoV-2 research [1]. As a result, in 2020, our research group presented a recommendation for PHTALOX mouthwash for reducing COVID-19 infection and progression [2]. On this occasion, we revealed the first clinical findings in patients with COVID-19who utilized PHTALOX, an antiviral phthalocyanine derivative (APD), in a gargle/rinse mouthwash protocol [3]. We updated the information with new insights on the usage of the

查看原文本刊更多论文

PHTALOX®预防新冠肺炎感染和进展的建议：科学方法的一年总结更新

尊敬的编辑：口腔在新冠肺炎的发生、发展和传播中的作用已被SARS-CoV-2研究的突破所揭示[1]。因此，在2020年，我们的研究小组提出了PHTALOX漱口水的建议，以减少新冠肺炎感染和进展[2]。在这次会议上，我们揭示了在漱口/漱口漱口方案中使用PHTALOX（一种抗病毒酞菁衍生物（APD））的新冠肺炎患者的首次临床发现[3]。我们更新了信息，对

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

GMS Hygiene and Infection Control PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

自引率

0.00%

发文量

审稿时长

10 weeks